Please login to the form below

Brazil

This page shows the latest Brazil news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more

The company will acquire rights to Seroquel and Seroquel XR in 51 countries and regions including China, the UK, Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia and other

Latest news

Pfizer drug gets speedy FDA review for rare heart failure complication

Since then, tafamidis has also been approved in other markets including Japan, Mexico, Argentina, Israel, South Korea and Brazil.
Merck KGaA inks deal for Medisafe adherence app

Merck KGaA inks deal for Medisafe adherence app. The digital programme will be initially rolled out in Brazil, Russia and Mexico. ... develop the apps initially for Brazil, Russia and Mexico.
Microsoft brings its AI network to cardiology

Launched last year as the Microsoft Intelligent Network for Eyecare (MINE), the work initially aimed to tackle visions problems through a collaboration with academic institutions in India, Brazil, Australia and the
Takeda gets FDA fast-track status for Zika vaccine

An outbreak of the virus in Brazil in 2015-16 resulted in almost 2, 000 infants born with microcephaly, while the US Centers for Disease Control and Prevention (CDC) says there ... Brazil declared the latest epidemic over last May, after a sharp
Bayer picks digital firms for open innovation support

Bayer received more than 450 digital health-related applications from 61 countries for its programme this year, with extremely strong bids from the US, Germany, Brazil and UK. .

More from news
Approximately 11 fully matching, plus 232 partially matching documents found.

Latest Intelligence

Creating a successful global compliance programme

Additionally, Brazil’s Clean Companies Act applies strict liability regarding interactions with public officials, and South Korea’s Kim Young-ran Act has adopted a broader definition of public officials that
Uncertainty, austerity and Brexit

Brazil and India all seeking to attract global investment, at the same time as the UK seeks to break away from the EU market.
Risky business for pharma

Risky business for pharma. China, Russia and Brazil are expected to provide the most issues. ... Across all sectors, the UK tied with Brazil for second place as the “market.
The ‘Million Hour Challenge’

For example, as part of ‘World Simplification Day’, simplification champions in AstraZeneca Brazil launched a ‘Waste Hunter’s Contest’ - an initiative built on lean principles. ... who likely would not have connected, actually come together to
The focus of global healthcare communication

Today, Vietnam, Russia and Brazil are equally as important as Spain or Germany to our clients.

More from intelligence
Approximately 7 fully matching, plus 40 partially matching documents found.

Latest appointments

IFPMA elects Pfizer’s Ian Read as president

He subsequently held a number of increasingly senior operational positions across Pfizer's Latin America business, including country manager for Pfizer Brazil and chief financial officer for Pfizer Mexico, before becoming
Ferring's Inna Demidova moves to ELC

ELC plans to open its Moscow office later this year and is eyeing further expansion in Brazil and China soon.
Takeda promotes Giles Platford

Prior to this he was general manager of Takeda Brazil, leading the acquisition of Multilab, a mid-sized company focused on branded generics and over-the-counter (OTC) products. ... The acquisition made Takeda one of the top 10 pharmaceutical groups
Daniel Sterzi joins Kantar Health Spain

Prior to this, he worked for GFK Customer Research France and Vivo (Telefónica Brazil), where he began his career as a marketing analyst.
Boehringer's Wolfram Carius to step down

He will leave Boehringer on June 30 as managing director responsible for biopharmaceuticals and production, after a career that included spells in Japan and Brazil. “

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

Webinar: The Brazil Conundrum

Webinar: The Brazil Conundrum. Conducting research in one of the world's largest pharma markets. ... Brazil is predicted to be the 6th largest pharmaceutical market in the world by 2014.
Nutrition Market in Brazil: Growth Against the Odds

Nutrition Market in Brazil: Growth Against the Odds. Published in eyeforpharma June 2017 by Marc Yates. ... Until the recession of 2014, Brazil saw a sustained period of strong growth in the functional foods and nutritional supplements market, albeit
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

However, 5 years on from the act, the three categories of medication in Brazil remain: “ originator” or “ reference” drugs, “ generic” drugs, and “ similares”. ... In fact the term “ similares” in Brazil is typically used
Competition from within

Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil, ... In this article, I will explore
Infographic: LATAM

Infographic: LATAM. Latin America. The LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth